Recombinant Human MAP4K1 Protein (Baculovirus)

MAP4K1, also known as mitogen-activated protein kinase kinase kinase 4, is a member of the MAP3K family and plays a crucial role in various cellular processes, including apoptosis, proliferation, and differentiation. Research on MAP4K1 has gained significance due to its involvement in key signaling pathways, particularly the c-Jun N-terminal kinase (JNK) and p38 MAPK pathways, which are critical for stress responses and inflammatory processes. Abnormal MAP4K1 activity has been linked to several diseases, including cancer, neurodegenerative disorders, and metabolic syndromes. Its pivotal role in these pathways makes MAP4K1 a potential therapeutic target for drug development. Recent studies have focused on the recombination and analysis of MAP4K1 protein to understand its structure-function relationship and regulatory mechanisms. By generating recombinant MAP4K1 proteins, researchers aim to elucidate its interactions with other proteins and signaling molecules. Moreover, the study of MAP4K1's functional domains via recombinant technology allows for detailed investigations into its enzymatic activity and downstream effects on cellular signaling. Understanding MAP4K1 at a molecular level is crucial for developing targeted therapies that can modulate its function in disease contexts, highlighting its potential as a promising target in biomedical research.